Literature DB >> 20096815

Ultra-short echo-time MRI detects changes in bone mineralization and water content in OVX rat bone in response to alendronate treatment.

S Anumula1, S L Wehrli, J Magland, A C Wright, F W Wehrli.   

Abstract

In this work we hypothesize that bisphosphonate treatment following ovariectomy manifests in increased phosphorus and decreased water concentration, both quantifiable nondestructively with ultra-short echo-time (UTE) (31)P and (1)H-MRI techniques. We evaluated this hypothesis in ovariectomized (OVX) rats undergoing treatment with two regimens of alendronate. Sixty female four-month-old rats were divided into four groups of 15 animals each: ovariectomized (OVX), OVX treatment groups ALN1 and ALN2, receiving 5 microg/kg/day and 25 microg/kg/day of alendronate, and a sham-operated group (NO) serving as control. Treatment, starting 1 week post-surgery, lasted for 50 days at which time animals were sacrificed. Whole bones from the left and right femora were extracted from all the animals. (31)P and (1)H water concentration were measured by UTE MRI at 162 and 400 MHz in the femoral shaft and the results compared with other measures of mineral and matrix properties obtained by (31)P solution NMR, CT density, ash weight, and water measured by dehydration. Mechanical parameters (elastic modulus, EM, and ultimate strength, US) were obtained by three-point bending. The following quantities were lower in OVX relative to NO: phosphorus concentration measured by (31)P-MRI (-8%; 11.4+/-0.9 vs. 12.4+/-0.8%, p<0.005), (31)P-NMR (-4%; 12.8+/-0.4 vs. 13.3+/-0.8 %, p<0.05) and micro-CT density (-2.5%; 1316+/-34 vs. 1349+/-32 mg/cm(3), p=0.005). In contrast, water concentration by (1)H-MRI was elevated in OVX relative to NO (+6%; 15.5+/-1.7 vs. 14.6+/-1.4 %, p<0.05). Alendronate treatment increased phosphorus concentration and decreased water concentration in a dose-dependent manner, the higher dose yielding significant changes relative to values found in OVX animals: (31)P-MRI (+14%; p<0.0001), (31)P-NMR (+9%; p<0.0001), ash content (+1.5%; p<0.005), micro-CT mineralization density (+2.8%; p<0.05), and (1)H-MRI, (-19%, p<0.0001). The higher dose raised phosphorus concentration above and water concentration below NO levels: (31)P-MRI (+6%; p<0.05), (31)P-NMR (+5%; p=0.01), ash content (+1.5%; p=0.005), (1)H-MRI (-14%; p<0.0001), and drying water (-10%; p<0.0005). Finally, the group means of phosphorus concentration were positively correlated with EM and US (R(2)> or =0.98, p<0.001 to p<0.05) even though the pooled data from individual animals were not. The results highlight the implications of estrogen depletion and bisphosphonate treatment on mineral composition and mechanical properties and the potential of solid-state MR imaging to detect these changes in situ in an animal model of rat ovariectomy. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096815      PMCID: PMC2854263          DOI: 10.1016/j.bone.2010.01.372

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  37 in total

1.  Changes in bone remodeling rate influence the degree of mineralization of bone.

Authors:  G Boivin; P J Meunier
Journal:  Connect Tissue Res       Date:  2002       Impact factor: 3.417

2.  Excised bone structures in mice: imaging at three-dimensional synchrotron radiation micro CT.

Authors:  Estela Martín-Badosa; Daniel Amblard; Stefania Nuzzo; Abdelmajid Elmoutaouakkil; Laurence Vico; Françoise Peyrin
Journal:  Radiology       Date:  2003-12       Impact factor: 11.105

3.  Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone.

Authors:  G Giavaresi; M Fini; S Gnudi; N N Aldini; M Rocca; A Carpi; R Giardino
Journal:  Biomed Pharmacother       Date:  2001-09       Impact factor: 6.529

4.  Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women.

Authors:  P Roschger; S Rinnerthaler; J Yates; G A Rodan; P Fratzl; K Klaushofer
Journal:  Bone       Date:  2001-08       Impact factor: 4.398

5.  Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women.

Authors:  G Y Boivin; P M Chavassieux; A C Santora; J Yates; P J Meunier
Journal:  Bone       Date:  2000-11       Impact factor: 4.398

Review 6.  Bisphosphonate mechanism of action.

Authors:  Gideon A Rodan; Alfred A Reszka
Journal:  Curr Mol Med       Date:  2002-09       Impact factor: 2.222

7.  Alterations of ovariectomized rat bone and impact of non-collagenous proteins on mineralization.

Authors:  Jian Huang; Xi Wang; Tian-Lan Zhang; Kui Wang
Journal:  Joint Bone Spine       Date:  2008-12-06       Impact factor: 4.929

8.  Density of organic matrix of native mineralized bone measured by water- and fat-suppressed proton projection MRI.

Authors:  Yaotang Wu; Jerome L Ackerman; David A Chesler; Lila Graham; Yan Wang; Melvin J Glimcher
Journal:  Magn Reson Med       Date:  2003-07       Impact factor: 4.668

9.  The degree of mineralization is a determinant of bone strength: a study on human calcanei.

Authors:  H Follet; G Boivin; C Rumelhart; P J Meunier
Journal:  Bone       Date:  2004-05       Impact factor: 4.398

10.  Water content measured by proton-deuteron exchange NMR predicts bone mineral density and mechanical properties.

Authors:  Maria A Fernández-Seara; Suzanne L Wehrli; Masaya Takahashi; Felix W Wehrli
Journal:  J Bone Miner Res       Date:  2003-12-16       Impact factor: 6.741

View more
  26 in total

1.  Review. The Agfa Mayneord lecture: MRI of short and ultrashort T₂ and T₂* components of tissues, fluids and materials using clinical systems.

Authors:  G M Bydder
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Deuterium nuclear magnetic resonance unambiguously quantifies pore and collagen-bound water in cortical bone.

Authors:  Henry H Ong; Alexander C Wright; Felix W Wehrli
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

3.  Bone mineral (31)P and matrix-bound water densities measured by solid-state (31)P and (1)H MRI.

Authors:  Alan C Seifert; Cheng Li; Chamith S Rajapakse; Mahdieh Bashoor-Zadeh; Yusuf A Bhagat; Alexander C Wright; Babette S Zemel; Antonios Zavaliangos; Felix W Wehrli
Journal:  NMR Biomed       Date:  2014-05-21       Impact factor: 4.044

Review 4.  The Role of Water Compartments in the Material Properties of Cortical Bone.

Authors:  Mathilde Granke; Mark D Does; Jeffry S Nyman
Journal:  Calcif Tissue Int       Date:  2015-03-18       Impact factor: 4.333

5.  Biochemical and Morphological Abnormalities of Subchondral Bone and Their Association with Cartilage Degeneration in Spontaneous Osteoarthritis.

Authors:  Pengling Ren; Haijun Niu; Haipeng Cen; Shaowei Jia; He Gong; Yubo Fan
Journal:  Calcif Tissue Int       Date:  2021-03-13       Impact factor: 4.333

6.  Bone mineral imaged in vivo by 31P solid state MRI of human wrists.

Authors:  Yaotang Wu; Timothy G Reese; Haihui Cao; Mirko I Hrovat; Steven P Toddes; Rostislav A Lemdiasov; Jerome L Ackerman
Journal:  J Magn Reson Imaging       Date:  2011-07-14       Impact factor: 4.813

Review 7.  Magnetic resonance of calcified tissues.

Authors:  Felix W Wehrli
Journal:  J Magn Reson       Date:  2013-01-10       Impact factor: 2.229

8.  Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging.

Authors:  Manuela Ventura; Yi Sun; Viorel Rusu; Peter Laverman; Paul Borm; Arend Heerschap; Egbert Oosterwijk; Otto C Boerman; John A Jansen; X Frank Walboomers
Journal:  Tissue Eng Part C Methods       Date:  2012-12-21       Impact factor: 3.056

Review 9.  PET-MRI for the Study of Metabolic Bone Disease.

Authors:  James S Yoder; Feliks Kogan; Garry E Gold
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

10.  Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties.

Authors:  Maxime A Gallant; Drew M Brown; Max Hammond; Joseph M Wallace; Jiang Du; Alix C Deymier-Black; Jonathan D Almer; Stuart R Stock; Matthew R Allen; David B Burr
Journal:  Bone       Date:  2014-01-24       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.